Brief: Iovance Biotherapeutics Says Confirming Resignation Of Chief Financial Officer Jean-Marc Bellemin, Effective July 10, 2025
26/06/2025 01:39
June 25 (Reuters) - Iovance Biotherapeutics Inc IOVA.O: IOVANCE BIOTHERAPEUTICS INC - CONFIRMING RESIGNATION OF CHIEF FINANCIAL OFFICER JEAN-MARC BELLEMIN, EFFECTIVE JULY 10, 2025 Source text: ID:nGNX5HG3Md Further company coverage: IOVA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iovance Biotherapeutics
See all newsBrief: Iovance Biotherapeutics Reports Inducement Grants
US RESEARCH ROUNDUP-BlackRock, Evercore, Goldman Sachs
Brief: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., As Chief Medical Officer
Iovance hits two-year high after raising annual revenue forecast
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies